Boston Medical Center is a non-profit 514-bed academic medical center in Boston, Massachusetts. It is the largest safety-net hospital and Level I trauma center in New England. BMC employs 1,466 physicians—including 711 residents and fellows—and 1,849 nurses.

There are 514 beds in Boston City Hosp / FGH-1.

During the past decade, Boston City Hosp / FGH-1 conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston City Hosp / FGH-1" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Kowa Pharmaceuticals America, Inc." with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "NEAT ID Foundation" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Boston City Hosp / FGH-1" are "HIV Infections" (7 trials), "Cardiovascular Diseases" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "Boston City Hosp / FGH-1" in a lesser frequency.

Most popular intervention types in "Boston City Hosp / FGH-1" are "Drug" (6 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (3 trials), "Delavirdine mesylate" (2 trials), "Lamivudine" (2 trials), "Atevirdine mesylate" (1 trials) and "Didanosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston City Hosp / FGH-1" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Boston City Hosp / FGH-1". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Boston City Hosp / FGH-1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston City Hosp / FGH-1, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".